Search - tctmd.com

Displaying 1 - 20 of 144

Sort: Relevancy | Date

Presentation TCT 2020

What Clinical Trials Are Needed to Support MCS in the Modern Era?

Presenter: Gregg Stone

October 16, 2020

Presentation TCT 2020

Regulatory Viewpoints on MCS Device Approval

Presenter: Meir Shinnar

October 16, 2020

Presentation TCT 2020

Heart Valve Collaboratory Is Next in Line

Presenter: Michael Mack

October 14, 2020

Presentation TCT 2020

Special Lecture: The "Pragmatic" Clinical Trial – A Brave New World or a Bridge Too Far!

Presenter: Robert Yeh

October 14, 2020

Presentation TCT 2019

Industry’s Perspectives on the US and Non-US EFS Landscape

Presenter: Neil Moat

September 26, 2019

Presentation TCT 2019

From EFS to Pivotal Trial: Bridging the Gap and Lessons Learned

Presenter: Pieter Kappetein

September 26, 2019

Presentation TCT 2019

Promoting Innovation Through EFS: MDIC Perspectives

Presenter: Chip Hance

September 26, 2019

Presentation TCT 2019

The US EFS and Breakthrough Devices Programs: An FDA Update

Presenter: Andrew Farb

September 26, 2019

Presentation TCT 2019

Keynote Lecture: A Vision for an Evolving Regulatory and Healthcare System

Presenter: Robert Califf

September 26, 2019

Presentation TCT 2019

Keynote Lecture: New Technology Assessment and Reimbursement Synergy — Forward Strides

Presenter: Lori Ashby

September 26, 2019

Presentation TCT 2019

Keynote Lecture: FDA/CDRH — The Year in Review, Focus on CDRH’s Total Product Life Cycle Concept

Presenter: William Maisel

September 26, 2019

Presentation TCT 2019

ISCTR Mission and Statement of Meeting Purpose

Presenter: Nabil Dib

September 25, 2019

Presentation TCT 2018

Patient Perspectives on Sham-Controlled Trials

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Debbe McCall

September 23, 2018

Presentation TCT 2018

FDA Perspectives on Sham-Controlled Trials

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Hiren Mistry

September 23, 2018

Presentation TCT 2018

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, David E. Kandzari

September 23, 2018

Presentation TCT 2018

ORBITA One Year Later: What Would I Do Differently, If Anything?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Rasha Al-Lamee

September 23, 2018

Presentation TCT 2018

EFS Experiences Grom the Industry Client Perspective: Whats Good and What Needs to Change?

Presenter: Andrew Farb, Martin B. Leon, Donald E. Bobo Jr

September 22, 2018

Presentation TCT 2018

EFS Decisions: Start-up Company Considerations

Presenter: Andrew Farb, Martin B. Leon, Beverly A Huss

September 22, 2018

Presentation TCT 2018

Promoting Medical Device Innovation: MDIC Perspectives

Presenter: Andrew Farb, Martin B. Leon, Liz McDermott

September 22, 2018

Presentation TCT 2018

The Second-Generation Cardiovascular EFS Pilot: Progress Report

Presenter: Andrew Farb, Martin B. Leon, David R. Holmes Jr.

September 22, 2018

Advertisement

What Clinical Trials Are Needed to Support MCS in the Modern Era?

Regulatory Viewpoints on MCS Device Approval

Heart Valve Collaboratory Is Next in Line

Special Lecture: The "Pragmatic" Clinical Trial – A Brave New World or a Bridge Too Far!

Industry’s Perspectives on the US and Non-US EFS Landscape

From EFS to Pivotal Trial: Bridging the Gap and Lessons Learned

Promoting Innovation Through EFS: MDIC Perspectives

The US EFS and Breakthrough Devices Programs: An FDA Update

Keynote Lecture: A Vision for an Evolving Regulatory and Healthcare System

Keynote Lecture: New Technology Assessment and Reimbursement Synergy — Forward Strides

Keynote Lecture: FDA/CDRH — The Year in Review, Focus on CDRH’s Total Product Life Cycle Concept

ISCTR Mission and Statement of Meeting Purpose

Patient Perspectives on Sham-Controlled Trials

FDA Perspectives on Sham-Controlled Trials

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

ORBITA One Year Later: What Would I Do Differently, If Anything?

EFS Experiences Grom the Industry Client Perspective: Whats Good and What Needs to Change?

EFS Decisions: Start-up Company Considerations

Promoting Medical Device Innovation: MDIC Perspectives

The Second-Generation Cardiovascular EFS Pilot: Progress Report

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content